المؤلفون: Caocci G., Mulas O., Abruzzese E., Luciano L., Iurlo A., Attolico I., Castagnetti F., Galimberti S., Sgherza N., Bonifacio M., Annunziata M., Gozzini A., Orlandi E. M., Stagno F., Binotto G., Pregno P., Fozza C., Trawinska M. M., De Gregorio F., Cattaneo D., Albano F., Gugliotta G., Barate C., Scaffidi L., Elena C., Pirillo F., Scalzulli E., La Nasa G., Foa R., Breccia M.

المساهمون: Caocci G., Mulas O., Abruzzese E., Luciano L., Iurlo A., Attolico I., Castagnetti F., Galimberti S., Sgherza N., Bonifacio M., Annunziata M., Gozzini A., Orlandi E.M., Stagno F., Binotto G., Pregno P., Fozza C., Trawinska M.M., De Gregorio F., Cattaneo D., Albano F., Gugliotta G., Barate C., Scaffidi L., Elena C., Pirillo F., Scalzulli E., La Nasa G., Foa R., Breccia M.

مصطلحات موضوعية: arterial occlusive event, chronic myeloid leukemia, ponatinib, prophylaxi, Adult, Aged, 80 and over, Aspirin, Cardiology, Coronary Occlusion, Decision Support Systems, Clinical, Female, Human, Hypertension, Imidazole, Incidence, Italy, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Male, Medical Oncology, Middle Aged, Pyridazine, Retrospective Studie, Risk Factor, Treatment Outcome, Young Adult

وصف الملف: STAMPA

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/30892724; info:eu-repo/semantics/altIdentifier/wos/WOS:000482514200009; volume:37; issue:3; firstpage:296; lastpage:302; numberofpages:7; journal:HEMATOLOGICAL ONCOLOGY; http://hdl.handle.net/11585/739518Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85064555696; http://onlinelibrary.wiley.com/journal/10.1002Test/(ISSN)1099-1069

الإتاحة: https://doi.org/10.1002/hon.2606Test
http://hdl.handle.net/11585/739518Test

المؤلفون: Caocci G., Mulas O., Capodanno I., Bonifacio M., Annunziata M., Galimberti S., Luciano L., Tiribelli M., Martino B., Castagnetti F., Binotto G., Pregno P., Stagno F., Abruzzese E., Bocchia M., Gozzini A., Albano F., Fozza C., Luzi D., Efficace F., Simula M. P., Scaffidi L., Barate C., De Gregorio F., Stella R., Gugliotta G., Pirillo F., Trawinska M. M., Sicuranza A., Cattaneo D., Attolico I., Scalzulli E., Iurlo A., Foa R., Breccia M., La Nasa G.

المساهمون: Caocci, G., Mulas, O., Capodanno, I., Bonifacio, M., Annunziata, M., Galimberti, S., Luciano, L., Tiribelli, M., Martino, B., Castagnetti, F., Binotto, G., Pregno, P., Stagno, F., Abruzzese, E., Bocchia, M., Gozzini, A., Albano, F., Fozza, C., Luzi, D., Efficace, F., Simula, M. P., Scaffidi, L., Barate, C., De Gregorio, F., Stella, R., Gugliotta, G., Pirillo, F., Trawinska, M. M., Sicuranza, A., Cattaneo, D., Attolico, I., Scalzulli, E., Iurlo, A., Foa, R., Breccia, M., La Nasa, G.

مصطلحات موضوعية: Arterial occlusive event, Cholesterol, Chronic myeloid leukemia, LDL, Nilotinib, Triglyceride, Adult, Aged, 80 and over, Antineoplastic Agent, Arterial Occlusive Disease, Dyslipidemia, Female, Human, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Lipoproteins, Male, Middle Aged, Pyrimidine, Risk Factor, Young Adult

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/33388860; info:eu-repo/semantics/altIdentifier/wos/WOS:000604466400001; volume:100; issue:8; firstpage:2005; lastpage:2014; numberofpages:10; journal:ANNALS OF HEMATOLOGY; http://hdl.handle.net/11568/1132892Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85098665618

الإتاحة: https://doi.org/10.1007/s00277-020-04392-wTest
http://hdl.handle.net/11568/1132892Test

المؤلفون: Fabio Stagno, Patrizia Pregno, Giovanni Caocci, Gianni Binotto, Robin Foà, Anna Sicuranza, Emilia Scalzulli, Francesca Pirillo, Mario Tiribelli, Isabella Capodanno, Antonella Gozzini, Massimiliano Bonifacio, Rossella Stella, Elisabetta Abruzzese, Massimo Breccia, Claudio Fozza, Gabriele Gugliotta, Giorgio La Nasa, Luigiana Luciano, Olga Mulas, Maria Pina Simula, Daniele Cattaneo, Mario Annunziata, Francesco Albano, Luigi Scaffidi, Fiorenza De Gregorio, Debora Luzi, Claudia Baratè, Malgorzata Monika Trawinska, Immacolata Attolico, Fabio Efficace, Sara Galimberti, Fausto Castagnetti, Monica Bocchia, Bruno Martino, Alessandra Iurlo

المساهمون: Caocci G., Mulas O., Capodanno I., Bonifacio M., Annunziata M., Galimberti S., Luciano L., Tiribelli M., Martino B., Castagnetti F., Binotto G., Pregno P., Stagno F., Abruzzese E., Bocchia M., Gozzini A., Albano F., Fozza C., Luzi D., Efficace F., Simula M.P., Scaffidi L., Barate C., De Gregorio F., Stella R., Gugliotta G., Pirillo F., Trawinska M.M., Sicuranza A., Cattaneo D., Attolico I., Scalzulli E., Iurlo A., Foa R., Breccia M., La Nasa G.

المصدر: Annals of hematology. 100(8)

مصطلحات موضوعية: Male, Arterial Occlusive Disease, Triglyceride, Gastroenterology, Antineoplastic Agent, chemistry.chemical_compound, 0302 clinical medicine, Risk Factors, 80 and over, Cumulative incidence, Chronic, Aged, 80 and over, Leukemia, Incidence (epidemiology), Chronic myeloid leukemia, Hematology, General Medicine, Middle Aged, Lipoproteins, LDL, Cholesterol, 030220 oncology & carcinogenesis, Low-density lipoprotein, Female, Human, medicine.drug, Adult, medicine.medical_specialty, Lipoproteins, Arterial occlusive event, Antineoplastic Agents, Arterial Occlusive Diseases, Lower risk, High cholesterol, LDL, 03 medical and health sciences, Young Adult, Internal medicine, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, medicine, Humans, Triglycerides, Aged, Dyslipidemias, business.industry, Risk Factor, Nilotinib, medicine.disease, Pyrimidines, Dyslipidemia, Pyrimidine, chemistry, BCR-ABL Positive, business, 030215 immunology, Myelogenous

وصف الملف: STAMPA

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0915a0416911a9810b7af9739e111328Test
https://pubmed.ncbi.nlm.nih.gov/33474630Test

المؤلفون: Mulas, Olga, Caocci, Giovanni, Stagno, Fabio, Bonifacio, Massimiliano, Annunziata, Mario, Luciano, Luigiana, Orlandi, Ester Maria, Abruzzese, Elisabetta, Sgherza, Nicola, Martino, Bruno, Albano, Francesco, Galimberti, Sara, Pregno, Patrizia, Bocchia, Monica, Castagnetti, Fausto, Tiribelli, Mario, Binotto, Gianni, Gozzini, Antonella, Capodanno, Isabella, Fozza, Claudio, Luzi, Debora, Efficace, Fabio, Simula, Maria Pina, Scaffidi, Luigi, De Gregorio, Fiorenza, Elena, Chiara, Trawinska, Malgorzata Monika, Cattaneo, Daniele, Attolico, Imma, Baratè, Claudia, Pirillo, Francesca, Sicuranza, Anna, Gugliotta, Gabriele, Stella, Rossella, Scalzulli, Emilia, Iurlo, Alessandra, Foà, Robin, Breccia, Massimo, La Nasa, Giorgio

المساهمون: Mulas, Olga, Caocci, Giovanni, Stagno, Fabio, Bonifacio, Massimiliano, Annunziata, Mario, Luciano, Luigiana, Orlandi, Ester Maria, Abruzzese, Elisabetta, Sgherza, Nicola, Martino, Bruno, Albano, Francesco, Galimberti, Sara, Pregno, Patrizia, Bocchia, Monica, Castagnetti, Fausto, Tiribelli, Mario, Binotto, Gianni, Gozzini, Antonella, Capodanno, Isabella, Fozza, Claudio, Luzi, Debora, Efficace, Fabio, Simula, Maria Pina, Scaffidi, Luigi, De Gregorio, Fiorenza, Elena, Chiara, Trawinska, Malgorzata Monika, Cattaneo, Daniele, Attolico, Imma, Baratè, Claudia, Pirillo, Francesca, Sicuranza, Anna, Gugliotta, Gabriele, Stella, Rossella, Scalzulli, Emilia, Iurlo, Alessandra, Foà, Robin, Breccia, Massimo, La Nasa, Giorgio

مصطلحات موضوعية: Arterial occlusive events, Chronic myeloid leukemia, Hypertension, Renin angiotensin system inhibitors, TKI, Adult, Aged, 80 and over, Angiotensin Receptor Antagonists, Angiotensin-Converting Enzyme Inhibitors, Cohort Studies, Drug Therapy, Combination, Female, Humans, Incidence, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Male, Middle Aged, Protein Kinase Inhibitors, Renin-Angiotensin System, Risk Factors, Survival Analysis, Thrombosis

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/32474619; info:eu-repo/semantics/altIdentifier/wos/WOS:000536450700001; volume:99; issue:7; firstpage:1525; lastpage:1530; numberofpages:6; journal:ANNALS OF HEMATOLOGY; http://hdl.handle.net/11562/1029204Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85085622798

الإتاحة: https://doi.org/10.1007/s00277-020-04102-6Test
http://hdl.handle.net/11562/1029204Test

المؤلفون: Mulas O., Caocci G., Annunziata M., Martino B., Luciano L., Castagnetti F., Pregno P., Galimberti S., Albano F., Orlandi E. M., Sgherza N., Iurlo A., Bonifacio M., Binotto G., Gozzini A., Bocchia M., Abruzzese E., Fozza C., Simula M. P., De Gregorio F., Gugliotta G., Pirillo F., Barate C., Attolico I., Elena C., Cattaneo D., Scaffidi L., Sicuranza A., Trawinska M. M., Scalzulli E., Foa R., Breccia M., La Nasa G.

المساهمون: Mulas, O., Caocci, G., Annunziata, M., Martino, B., Luciano, L., Castagnetti, F., Pregno, P., Galimberti, S., Albano, F., Orlandi, E. M., Sgherza, N., Iurlo, A., Bonifacio, M., Binotto, G., Gozzini, A., Bocchia, M., Abruzzese, E., Fozza, C., Simula, M. P., De Gregorio, F., Gugliotta, G., Pirillo, F., Barate, C., Attolico, I., Elena, C., Cattaneo, D., Scaffidi, L., Sicuranza, A., Trawinska, M. M., Scalzulli, E., Foa, R., Breccia, M., La Nasa, G.

مصطلحات موضوعية: Adult, Aged, 80 and over, Disease-Free Survival, Female, Follow-Up Studie, Human, Male, Middle Aged, Pyrimidine, Survival Rate, Chromosomes, Pair 22, Pair 9, Fusion Proteins, bcr-abl, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, RNA, Messenger, Neoplasm, Translocation, Genetic

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/32602167; info:eu-repo/semantics/altIdentifier/wos/WOS:000551227600001; volume:38; issue:4; firstpage:607; lastpage:610; numberofpages:4; journal:HEMATOLOGICAL ONCOLOGY; https://hdl.handle.net/11568/1069057Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85088293296

الإتاحة: https://doi.org/10.1002/hon.2765Test
https://hdl.handle.net/11568/1069057Test

المؤلفون: Chiara Elena, Alessandra Iurlo, Antonella Gozzini, Giorgio La Nasa, Claudia Baratè, Gabriele Gugliotta, Bruno Martino, Francesca Pirillo, Fiorenza De Gregorio, Fabio Efficace, Monica Bocchia, Massimo Breccia, Claudio Fozza, Elisabetta Abruzzese, Mario Annunziata, Sara Galimberti, Gianni Binotto, Fabio Stagno, Isabella Capodanno, Malgorzata Monika Trawinska, Anna Sicuranza, Maria Pina Simula, Robin Foà, Debora Luzi, Patrizia Pregno, Rossella Stella, Imma Attolico, Luigiana Luciano, Francesco Albano, Giovanni Caocci, Ester Orlandi, Daniele Cattaneo, Olga Mulas, Nicola Sgherza, Luigi Scaffidi, Massimiliano Bonifacio, Emilia Scalzulli, Mario Tiribelli, Fausto Castagnetti

المساهمون: Mulas O., Caocci G., Stagno F., Bonifacio M., Annunziata M., Luciano L., Orlandi E.M., Abruzzese E., Sgherza N., Martino B., Albano F., Galimberti S., Pregno P., Bocchia M., Castagnetti F., Tiribelli M., Binotto G., Gozzini A., Capodanno I., Fozza C., Luzi D., Efficace F., Simula M.P., Scaffidi L., De Gregorio F., Elena C., Trawinska M.M., Cattaneo D., Attolico I., Barate C., Pirillo F., Sicuranza A., Gugliotta G., Stella R., Scalzulli E., Iurlo A., Foa R., Breccia M., La Nasa G.

المصدر: Annals of hematology. 99(7)

مصطلحات موضوعية: Male, Myeloid, Angiotensin-Converting Enzyme Inhibitors, Gastroenterology, Cohort Studies, Renin-Angiotensin System, chemistry.chemical_compound, 0302 clinical medicine, Risk Factors, 80 and over, Cumulative incidence, Chronic, Aged, 80 and over, Leukemia, Arterial occlusive events, Incidence, Ponatinib, Angiotensin Receptor Antagonist, Chronic myeloid leukemia, Myeloid leukemia, Hematology, General Medicine, Middle Aged, TKI, Dasatinib, medicine.anatomical_structure, 030220 oncology & carcinogenesis, Combination, Hypertension, Drug Therapy, Combination, Female, Survival Analysi, medicine.drug, Human, Renin angiotensin system inhibitors, Adult, medicine.medical_specialty, Arterial occlusive event, Protein Kinase Inhibitor, 03 medical and health sciences, Angiotensin Receptor Antagonists, Drug Therapy, Internal medicine, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, medicine, Humans, Artery occlusion, Protein Kinase Inhibitors, Aged, business.industry, Risk Factor, Angiotensin-Converting Enzyme Inhibitor, Thrombosis, Renin angiotensin system inhibitor, Survival Analysis, Blood pressure, chemistry, Nilotinib, BCR-ABL Positive, Cohort Studie, business, 030215 immunology, Myelogenous

وصف الملف: STAMPA

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::adf8c41d8279e9ac1b91f66c2e7b6133Test
https://pubmed.ncbi.nlm.nih.gov/32474619Test

المؤلفون: Sara Galimberti, Giovanni Caocci, Ester Orlandi, Mario Annunziata, Gabriele Gugliotta, Emilia Scalzulli, Alessandra Iurlo, Chiara Elena, Elisabetta Abruzzese, Daniele Cattaneo, Bruno Martino, Malgorzata Monika Trawinska, Giorgio La Nasa, Luigi Scaffidi, Francesca Pirillo, Anna Sicuranza, Luigiana Luciano, Fausto Castagnetti, Patrizia Pregno, Monica Bocchia, Nicola Sgherza, Francesco Albano, Robin Foà, Massimo Breccia, Fiorenza De Gregorio, Antonella Gozzini, Massimiliano Bonifacio, Claudia Baratè, Imma Attolico, Maria Pina Simula, Gianni Binotto, Claudio Fozza, Olga Mulas

المساهمون: Mulas O., Caocci G., Annunziata M., Martino B., Luciano L., Castagnetti F., Pregno P., Galimberti S., Albano F., Orlandi E.M., Sgherza N., Iurlo A., Bonifacio M., Binotto G., Gozzini A., Bocchia M., Abruzzese E., Fozza C., Simula M.P., De Gregorio F., Gugliotta G., Pirillo F., Barate C., Attolico I., Elena C., Cattaneo D., Scaffidi L., Sicuranza A., Trawinska M.M., Scalzulli E., Foa R., Breccia M., La Nasa G.

مصطلحات موضوعية: Oncology, Male, Cancer Research, Chromosomes, Human, Pair 22, bcr-abl, Messenger, Fusion Proteins, bcr-abl, Translocation, Genetic, 80 and over, Favorable outcome, RNA, Neoplasm, Chronic, Aged, 80 and over, Leukemia, Follow up studies, Myeloid leukemia, molecular response, Hematology, General Medicine, Middle Aged, Survival Rate, outcome, Female, Chromosomes, Human, Pair 9, medicine.drug, Human, Pair 9, Adult, medicine.medical_specialty, Disease free survival, transcript type, MEDLINE, Translocation, Disease-Free Survival, Chromosomes, Follow-Up Studie, Text mining, Genetic, chronic myeloid leukemia, Internal medicine, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, medicine, Humans, RNA, Messenger, Survival rate, nilotinib, Aged, Follow-Up Studies, Pyrimidines, business.industry, chronic myeloid leukemia, nilotinib, transcript type, molecular response, outcome, Fusion Proteins, Nilotinib, Pyrimidine, RNA, Neoplasm, BCR-ABL Positive, Pair 22, business, Myelogenous

وصف الملف: STAMPA

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::955bdbedede7910abffefc245f430004Test
https://hdl.handle.net/11365/1115020Test

المؤلفون: Caocci, Giovanni, Mulas, Olga, Bonifacio, Massimiliano, Abruzzese, Elisabetta, Galimberti, Sara, Orlandi, Ester Maria, Iurlo, Alessandra, Annunziata, Mario, Luciano, Luigiana, Castagnetti, Fausto, Gozzini, Antonella, Stagno, Fabio, Binotto, Gianni, Pregno, Patrizia, Albano, Francesco, Martino, Bruno, Fozza, Claudio, Scaffidi, Luigi, Trawinska, Malgorzata Monika, Baratè, Claudia, Elena, Chiara, Cattaneo, Daniele, Scalzulli, Emilia, La Nasa, Giorgio, Foà, Robin, Breccia, Massimo

المساهمون: Caocci, Giovanni, Mulas, Olga, Bonifacio, Massimiliano, Abruzzese, Elisabetta, Galimberti, Sara, Orlandi, Ester Maria, Iurlo, Alessandra, Annunziata, Mario, Luciano, Luigiana, Castagnetti, Fausto, Gozzini, Antonella, Stagno, Fabio, Binotto, Gianni, Pregno, Patrizia, Albano, Francesco, Martino, Bruno, Fozza, Claudio, Scaffidi, Luigi, Trawinska, Malgorzata Monika, Baratè, Claudia, Elena, Chiara, Cattaneo, Daniele, Scalzulli, Emilia, La Nasa, Giorgio, Foà, Robin, Breccia, Massimo

مصطلحات موضوعية: Chronic myeloid leukemia, Recurrent arterial occlusive event, Secondary prophylaxi, Aged, 80 and over, Anticoagulant, Arterial Occlusive Disease, Female, Follow-Up Studie, Human, Incidence, Italy, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Male, Middle Aged, Platelet Aggregation Inhibitor, Protein Kinase Inhibitor, Recurrence, Risk Factor, Secondary Prevention, Time Factor, Treatment Outcome

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/31029498; info:eu-repo/semantics/altIdentifier/wos/WOS:000467812500044; volume:288; firstpage:124; lastpage:127; numberofpages:4; journal:INTERNATIONAL JOURNAL OF CARDIOLOGY; http://hdl.handle.net/11562/1015813Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85064545541

الإتاحة: https://doi.org/10.1016/j.ijcard.2019.04.051Test
http://hdl.handle.net/11562/1015813Test

المؤلفون: Caocci, Giovanni, Mulas, Olga, Abruzzese, Elisabetta, Iurlo, Alessandra, Annunziata, Mario, Orlandi, Ester Maria, Galimberti, Sara, Binotto, Gianni, Sgherza, Nicola, Luciano, Luigia, Martino, Bruno, Russo Rossi, Antonella, Bonifacio, Massimiliano, Fozza, Claudio, Trawinska, Malgorzata Monika, Cattaneo, Daniele, Elena, Chiara, Baratè, Claudia, De Gregorio, Fiorenza, Molica, Matteo, La Nasa, Giorgio, Foà, Robin, Breccia, Massimo

المساهمون: Caocci, Giovanni, Mulas, Olga, Abruzzese, Elisabetta, Iurlo, Alessandra, Annunziata, Mario, Orlandi, Ester Maria, Galimberti, Sara, Binotto, Gianni, Sgherza, Nicola, Luciano, Luigia, Martino, Bruno, Russo Rossi, Antonella, Bonifacio, Massimiliano, Fozza, Claudio, Trawinska, Malgorzata Monika, Cattaneo, Daniele, Elena, Chiara, Baratè, Claudia, De Gregorio, Fiorenza, Molica, Matteo, La Nasa, Giorgio, Foà, Robin, Breccia, Massimo

مصطلحات موضوعية: Acetylsalicylic acid, Bosutinib, Cardiovascular risk, Chronic myeloid leukemia, Adult, Aged, 80 and over, Angina Pectori, Aniline Compound, Antineoplastic Agent, Brain Ischemia, Dasatinib, Disease Susceptibility, Drug Administration Schedule, Female, Human, Imatinib Mesylate, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Male, Middle Aged, Myocardial Infarction, Nitrile, Peripheral Vascular Disease, Protein Kinase Inhibitor, Pyrimidine, Quinoline, Retrospective Studies

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/31044260; info:eu-repo/semantics/altIdentifier/wos/WOS:000475694100009; volume:98; issue:8; firstpage:1885; lastpage:1890; numberofpages:6; journal:ANNALS OF HEMATOLOGY; http://hdl.handle.net/11562/1015815Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85065256448

الإتاحة: https://doi.org/10.1007/s00277-019-03705-yTest
http://hdl.handle.net/11562/1015815Test

المؤلفون: Claudio Fozza, Giovanni Caocci, Ester Orlandi, Massimiliano Bonifacio, Chiara Elena, Bruno Martino, Daniele Cattaneo, Mario Annunziata, Luigi Scaffidi, Antonella Gozzini, Sara Galimberti, Olga Mulas, Fabio Stagno, Gianni Binotto, Patrizia Pregno, Giorgio La Nasa, Robin Foà, Fausto Castagnetti, Alessandra Iurlo, Malgorzata Monika Trawinska, Massimo Breccia, Emilia Scalzulli, Luigiana Luciano, Francesco Albano, Claudia Baratè, Elisabetta Abruzzese

المساهمون: Caocci G., Mulas O., Bonifacio M., Abruzzese E., Galimberti S., Orlandi E.M., Iurlo A., Annunziata M., Luciano L., Castagnetti F., Gozzini A., Stagno F., Binotto G., Pregno P., Albano F., Martino B., Fozza C., Scaffidi L., Trawinska M.M., Barate C., Elena C., Cattaneo D., Scalzulli E., La Nasa G., Foa R., Breccia M.

مصطلحات موضوعية: Oncology, Male, Time Factors, 030204 cardiovascular system & hematology, chemistry.chemical_compound, 0302 clinical medicine, Recurrent arterial occlusive event, Recurrence, Risk Factors, 80 and over, Secondary Prevention, Medicine, Cumulative incidence, 030212 general & internal medicine, Chronic, Aged, 80 and over, Chronic myeloid leukemia, Secondary prophylaxis, Leukemia, Incidence (epidemiology), Incidence, Ponatinib, Myeloid leukemia, Middle Aged, Aged, Anticoagulants, Arterial Occlusive Diseases, Female, Follow-Up Studies, Humans, Italy, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Platelet Aggregation Inhibitors, Protein Kinase Inhibitors, Treatment Outcome, Dasatinib, Platelet aggregation inhibitor, Cardiology and Cardiovascular Medicine, Bosutinib, medicine.drug, medicine.medical_specialty, 03 medical and health sciences, Internal medicine, business.industry, chemistry, Nilotinib, BCR-ABL Positive, business, Myelogenous

وصف الملف: STAMPA

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::12faa9952d66192041e7ea10bcb6407aTest
http://hdl.handle.net/11562/1015813Test